Welcome to LookChem.com Sign In|Join Free
  • or
(E,E)-Farnesyl phenylsulfone is a chemical compound belonging to the class of phenylsulfones and is derived from the hydrocarbon farnesol. It is recognized for its potential as an antimicrobial agent, exhibiting activity against various pathogens, including bacteria and fungi. Furthermore, research has revealed its antioxidant and anti-inflammatory properties, which make it a promising candidate for pharmaceutical and therapeutic applications. (E,E)-farnesyl phenylsulfone is also being explored for its potential use in the development of new materials and as a precursor for the synthesis of other bioactive molecules.

56881-53-9

Post Buying Request

56881-53-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56881-53-9 Usage

Uses

Used in Pharmaceutical and Therapeutic Applications:
(E,E)-Farnesyl phenylsulfone is used as an antimicrobial agent for its activity against a range of bacteria and fungi, making it a potential candidate for treating various infections.
Used in Antioxidant and Anti-Inflammatory Applications:
(E,E)-Farnesyl phenylsulfone is used as an antioxidant and anti-inflammatory agent due to its demonstrated properties, which could be beneficial in the development of treatments for conditions associated with oxidative stress and inflammation.
Used in Material Science:
(E,E)-Farnesyl phenylsulfone is used as a building block for the development of new materials, leveraging its unique chemical properties to create innovative substances with potential applications in various industries.
Used in Chemical Synthesis:
(E,E)-Farnesyl phenylsulfone is used as a precursor in the synthesis of other bioactive molecules, contributing to the advancement of pharmaceutical research and the development of new therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 56881-53-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,8,8 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56881-53:
(7*5)+(6*6)+(5*8)+(4*8)+(3*1)+(2*5)+(1*3)=159
159 % 10 = 9
So 56881-53-9 is a valid CAS Registry Number.

56881-53-9Relevant academic research and scientific papers

Synthesis and enzymatic cyclization of (3S)11-fluoro-2,3-oxidosqualene

Robustell, Brian,Ikuro, Abe,Prestwich, Glenn D.

, p. 957 - 960 (1998)

A convergent asymmetric synthesis provided (3S)11-fluoro-2,3- oxidosqualene (11-FOS, 14), which was cyclized by bacterial squalene:hopane cyclase to a bridged ether. 11-FOS was neither a substrate nor an inhibitor for vertebrate oxidosqualene:lanosterol c

CHINONE-, HYDROCHINOME- AND NAPHTHOCHINONE-ANALOGUES OF VATIQUIONE FOR TREATMENT OF MITOCHONDRIAL DISORDER DISEASES

-

Page/Page column 187, (2021/04/10)

The disclosure provides therapeutic compositions (i.e., therapeutic agents) and methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with Friedreich's ataxia (e.g. Complex I deficiency), and/or reducing the likelihood or severity of Friedreich's ataxia. The disclosure further provides novel intermediates for the production of said therapeutic compositions and related reduced versions of said therapeutic compositions, which reduce forms may also be used as therapeutic agents (or prodrugs of the therapeutic agent(s)).

Synergistic factors ensue high expediency in the synthesis of menaquinone [K2] analogue MK-6: Application to access an efficient one-pot protocol to MK-9

Yerramsetti, Nanaji,Dampanaboina, Lavanya,Mendu, Venugopal,Battula, Satyanarayana

, (2020/11/12)

Here we report a practical and efficient method for the synthesis of menaquinone vitamin (K2) analog MK-6 in all trans forms through “1 + 5 convergent synthetic approach” of pentaprenyl chloride with monoprenyl menadione derivative. In the synergistic factors, less efficient leaving group/more efficient nucleophile (Cl) in the substrate makes it more prominent reaction by eliminating all Sn2’ side reaction products. Further, the addition of acetic acid in the last step (desulfonation) of reaction sequence removes the limitations of the reactions in terms of cyclized side product (multiple reactions of pentaprenyl alcohol with Et3B), byproduct (Et3B, incendiary compound) formations and their interruption in the tricky purification processes. The utility of this method was further extended to find an efficient one-pot synthesis to MK-9 to the gram scale synthesis. This approach is economical and efficient and avoids the awkward chromatographic separation processes.

SYNTHESIS OF E,E-FARNESOL, FARNESYL ACETATE AND SQUALENE FROM FARNESENE VIA FARNESYL CHLORIDE

-

Paragraph 0086; 0087, (2019/12/28)

The present disclosure provides methods for preparing polyunsaturated hydrocarbons, such as E,E-farnesol, farnesyl acetate and squalene, by base catalyzed addition of a dialkylamine to a 3-methylene-1-alkene, such as farnesene. The present disclosure also provides compositions including one more farnesene derivatives prepared using the disclosed methods.

Characterization of the single-subunit oligosaccharyltransferase STT3A from Trypanosoma brucei using synthetic peptides and lipid-linked oligosaccharide analogs

Ramírez, Ana S.,Boilevin, Jérémy,Biswas, Rasomoy,Gan, Bee Ha,Janser, Daniel,Aebi, Markus,Darbre, Tamis,Reymond, Jean-Louis,Locher, Kaspar P.

, p. 525 - 535 (2017/06/09)

The initial transfer of a complex glycan in protein N-glycosylation is catalyzed by oligosaccharyltransferase (OST), which is generally a multisubunit membrane protein complex in the endoplasmic reticulum but a single-subunit enzyme (ssOST) in some protists. To investigate the reaction mechanism of ssOST, we recombinantly expressed, purified and characterized the STT3A protein from Trypanosoma brucei (TbSTT3A). We analyzed the in vitro activity of TbSTT3A by synthesizing fluorescently labeled acceptor peptides as well as lipid-linked oligosaccharide (LLO) analogs containing a chitobiose moiety coupled to oligoprenyl carriers of distinct lengths (C10, C15, C20 and C25) and with different double bond stereochemistry. We found that in addition to proline, charged residues at the +1 position of the sequon inhibited glycan transfer. An acidic residue at the -2 position significantly increased catalytic turnover but was not essential, in contrast to the bacterial OST. While all synthetic LLO analogs were processed by TbSTT3A, the length of the polyprenyl tail, but not the stereochemistry of the double bonds, determined their apparent affinity. We also synthesized phosphonate analogs of the LLOs, which were found to be competitive inhibitors of the reaction, although with lower apparent affinity to TbSTT3A than the active pyrophosphate analogs.

Convergent Synthesis of Menaquinone-7 (MK-7)

Baj, Aneta,Wa?ejko, Piotr,Kutner, Andrzej,Kaczmarek, ?ukasz,Morzycki, Jacek W.,Witkowski, Stanis?aw

, p. 1026 - 1033 (2016/11/11)

A practical synthesis of menaquinone-7 (MK-7, Vitamin K2) in the all-trans form was designed. Stereoselective synthesis of MK-7 was achieved through a "1 + 6" convergent strategy by condensation of two building blocks, menadione monoprenyl derivative (fragment "1") with hexaprenyl bromide (fragment "6", 82%). Pd-catalyzed desulfonation with LiEt3BH (78%) was followed by oxidation of the hydroquinone moiety using ammonium cerium(IV) nitrate (72%). The major challenge in our methodology was the preparation of all-trans hexaprenyl bromide by coupling of two triprenyl units derived from trans, trans-farnesol. Manufacturing on a pilot scale was accomplished through our approach. The scalable method was designed especially for a large, kilogram-scale production from easily available intermediates. Furthermore, the proposed methodology avoids many chromatographic purifications and allows for a relatively cost-effective manufacturing. Moreover, our synthesis yielded high-purity (99.9%) final product MK-7, which can be used as a dietary supplement as well as an active pharmaceutical ingredient.

Convergent synthesis of menaquinone-7 (MK-7)

Baj, Aneta,Wa?ejko, Piotr,Kutner, Andrzej,Kaczmarek, L?ukasz,Morzycki, Jacek W,Witkowski, Stanisl?aw

, p. 1026 - 1033 (2017/01/16)

A practical synthesis of menaquinone-7 (MK-7, vitamin K2) in the all-Trans form was designed. Stereoselective synthesis of MK-7 was achieved through a "1 + 6" convergent strategy by condensation of two building blocks, menadione monoprenyl derivative (fragment "1") with hexaprenyl bromide (fragment "6", 82%). Pd-catalyzed desulfonation with LiEt3BH (78%) was followed by oxidation of the hydroquinone moiety using ammonium cerium(IV) nitrate (72%). The major challenge in our methodology was the preparation of all-Trans hexaprenyl bromide by coupling of two triprenyl units derived from trans,trans-farnesol. Manufacturing on a pilot scale was accomplished through our approach. The scalable method was designed especially for a large, kilogram-scale production from easily available intermediates. Furthermore, the proposed methodology avoids many chromatographic purifications and allows for a relatively cost-effective manufacturing. Moreover, our synthesis yielded high-purity (99.9%) final product MK-7, which can be used as a dietary supplement as well as an active pharmaceutical ingredient.

Total synthesis of the proposed structure of astakolactin

Tonoi, Takayuki,Mameda, Keisuke,Fujishiro, Moe,Yoshinaga, Yutaka,Shiina, Isamu

supporting information, p. 2421 - 2427 (2014/12/12)

The first total synthesis of the proposed structure of astakolactin, a sesterterpene metabolite isolated from the marine sponge Cacospongia scalaris, has been achieved, mainly featuring Johnson-Claisen rearrangement, asymmetric Mukaiyama aldol reaction an

PROCESS FOR PREPARATION OF MK-7 TYPE OF VITAMIN K2

-

Page/Page column 26; 27, (2014/05/07)

Process for preparation of MK-7 type of vitamin K2 is characterized by attaching hexaprenyl chain of ?all-trans" configuration to monoprenyl derivative of menadiol following ?1 + 6" synthetic strategy. According to the invention, a-sulfonyl carbanion generated in situ from the protected monoprenyl menadiol of the formula (II), wherein R1 represents C1-3-alkyl group, is reacted with hexaprenyl halide of the formula (VII), wherein X represents halogen atom, preferably bromine, both Z' and Z' represent H or one of Z' and Z" represents H and the other represents phenylsulfonyl group -SO2Ph in the alkylation reaction. The hexaprenyl halide of formula (VII) is obtained by coupling two triprenyl units in alkylation reaction, with or without separation of the intermediates.

Concise synthesis and structure-activity relationship of furospinosulin-1, a hypoxia-selective growth inhibitor from marine sponge

Kotoku, Naoyuki,Fujioka, Shinichi,Nakata, Chiaki,Yamada, Masaki,Sumii, Yuji,Kawachi, Takashi,Arai, Masayoshi,Kobayashi, Motomasa

experimental part, p. 6673 - 6678 (2011/09/30)

Structure-activity relationship of furospinosulin-1 (1), a hypoxia-selective growth inhibitor isolated from marine sponge, was investigated. Concise synthetic method of 1 was developed, and some structurally modified analogues were prepared. Biological evaluation of them revealed that the whole chemical structure was important for the hypoxia-selective growth inhibitory activity of 1. Among prepared, the desmethyl analogue 30 showed excellent hypoxia-selective inhibitory activity similar to that of 1 and also exhibited in vivo anti-tumor activity with oral administration.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56881-53-9